Nephroplus Acquires 100% Stake in Kazakhstan Dialysis Center for ₹116 Crore
Nephroplus, through its subsidiary NPHSK LLP, will acquire a 100% stake in Dialysis Center Almaty LLP in Kazakhstan for KZT 561.66 million (approx. ₹116.35 million). The acquisition strengthens NEPHROPLUS's international network and presence in Kazakhstan. Completion is subject to conditions precedent.
The acquisition is of a foreign subsidiary and while strategic, it is not a merger or acquisition of a significantly large entity that would drastically alter the company's financials or market position in the short term. However, it represents a step towards international growth.
The acquisition is a strategic move to expand the company's international presence and is expected to strengthen its position in Kazakhstan, which is a positive development for the company.
Nephrocare Health Services Limited (NEPHROPLUS) announced that its overseas step-down subsidiary, NEPHROPLUS HEALTH SERVICES KAZAKHSTAN LLP (NPHSK LLP), has entered into a Sale and Purchase Agreement (SPA) to acquire a 100% participatory interest in Dialysis Center Almaty LLP, a limited liability partnership in Kazakhstan. The acquisition was finalized on September 1, 2026.
The aggregate consideration for this acquisition is KZT 561.66 million (approximately ₹116.35 million), subject to potential downward adjustments as per the SPA's terms. Dialysis Center Almaty LLP, incorporated on February 22, 2019, provides dialysis services through its centers in Kazakhstan and operates 34 dialysis machines. Its last audited turnover was KZT 527.44 million (approximately ₹10.93 crore).
This strategic move aligns with NEPHROPLUS's objective to expand its dialysis services network in international markets, particularly strengthening its presence and operational platform in Kazakhstan. The transaction is not a related party transaction, and the promoters or group companies have no interest in the acquired entity. The completion of the acquisition is contingent upon the fulfillment or waiver of certain conditions precedent and closing actions outlined in the SPA. Upon completion, Dialysis Center Almaty LLP will become an overseas step-down subsidiary of NEPHROPLUS.
A plain-language summary of a public exchange filing by Nephrocare Health Services Limited. Read the original for the full detail.